Bevyxxa Will Join Other Anticoagulant Meds on the Market

You may see some patients get Bevyxxa (beh-VYKE-sah, betrixaban), a new direct oral anticoagulant (DOAC).

It's not used the same way as other DOACs...Pradaxa (dabigatran), Xarelto (rivaroxaban), Eliquis (apixaban), or Savaysa (edoxaban).

Bevyxxa is only approved to PREVENT blood clots in the leg or lungs in certain hospitalized adults with multiple risk factors...such as reduced mobility plus older age and heart failure.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals